Bismuth, moxifloxacin, tetracycline, lansoprazole quadruple first line therapy for eradication of H. pylori: A prospective study

被引：8
|
作者：
Ergul, Bilal [1 ]
Kocak, Erdem [1 ]
Tas, Adnan [1 ]
Filik, Levent [1 ]
Koklu, Seyfettin [1 ]
机构：
[1] Ankara Educ & Res Hosp, Ankara, Turkey
来源：
CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY | 2013年 / 37卷 / 05期
关键词：
HELICOBACTER-PYLORI; TRIPLE THERAPY; 1ST-LINE TREATMENT; CONSENSUS REPORT; INFECTION; CLARITHROMYCIN; SUBSALICYLATE; ESOMEPRAZOLE; PROTECTION; MANAGEMENT;
D O I：
10.1016/j.clinre.2012.10.014
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：527 / 529
页数：3
相关论文
共 50 条
  • [1] The Efficacy of Two-Week Quadruple First-Line Therapy with Bismuth, Lansoprazole, Amoxicillin, Clarithromycin on Helicobacter pylori Eradication: A Prospective Study
    Ergul, Bilal
    Dogan, Zeynal
    Sarikaya, Murat
    Filik, Levent
    [J]. HELICOBACTER, 2013, 18 (06) : 454 - 458
  • [2] Moxifloxacin-Tetracycline-Lansoprazole Triple Therapy for First-Line Treatment of Helicobacter pylori Infection: A Prospective Study
    Tas, Adnan
    Akbal, Erdem
    Kocak, Erdem
    Koklu, Seyfettin
    [J]. HELICOBACTER, 2011, 16 (01) : 52 - 54
  • [3] Moxifloxacin Containing Triple Therapy vs. Moxifloxacin and Bismuth-Containing Quadruple Therapy for First-Line Treatment of Helicobacter pylori (H. pylori) Infection
    Ciccaglione, Antonio Francesco
    Cellini, Luigina
    Grossi, Laurino
    Di Tullio, Ada Maria
    Pagliaro, Mauro
    Tavani, Roberta
    Cocciolillo, Sila
    Marzio, Leonardo
    [J]. GASTROENTEROLOGY, 2012, 142 (05) : S482 - S482
  • [4] The exposure of antibiotics on the eradication of bismuth quadruple therapy in H. pylori infection
    聂尚姝
    [J]. China Medical Abstracts (Internal Medicine), 2022, (01) : 47 - 48
  • [5] Quadruple, sequential, and concomitant first-line therapies for H. pylori eradication: a prospective, randomized study
    De Francesco, Vincenzo
    Pontone, Stefano
    Bellesia, Annamaria
    Serviddio, Gaetano
    Panetta, Cristina
    Palma, Rossella
    Zullo, Angelo
    [J]. DIGESTIVE AND LIVER DISEASE, 2018, 50 (02) : 139 - 141
  • [6] Quadruple therapy with moxifloxacin and bismuth for first-line treatment of Helicobacter pylori
    Ciccaglione, Antonio Francesco
    Cellini, Luigina
    Grossi, Laurino
    Marzio, Leonardo
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2012, 18 (32) : 4386 - 4390
  • [7] Quadruple therapy with moxifloxacin and bismuth for first-line treatment ofHelicobacter pylori
    Antonio Francesco Ciccaglione
    Luigina Cellini
    Laurino Grossi
    Leonardo Marzio
    [J]. World Journal of Gastroenterology, 2012, (32) : 4386 - 4390
  • [8] Prospective comparative study between two first-line regimens for Helicobacter pylori eradication: Non-bismuth quadruple versus bismuth quadruple therapy
    Alcedo, Javier
    Gracia, Marta
    Garcia-Camara, Paula
    Palacin, Carmen
    Gallego, Sonia
    Jimeno-Ayllon, Cristina
    Frago, Santiago
    Aured, Isabel
    Luzon, Lara
    [J]. GASTROENTEROLOGIA Y HEPATOLOGIA, 2020, 43 (06): : 301 - 309
  • [9] Single Capsule Bismuth Quadruple Therapy for Eradication of H. pylori Infection: A Real-Life Study
    Gravina, Antonietta G.
    Priadko, Kateryna
    Granata, Lucia
    Facchiano, Angela
    Scida, Giuseppe
    Cerbone, Rosa
    Ciamarra, Paola
    Romano, Marco
    [J]. FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [10] Doxycycline-based first-line quadruple therapy:: Benefit of H. pylori eradication in children
    Nijevitch, A. A.
    Akhmadeyeva, E. N.
    Nasretdinova, E. K.
    Sataev, V. U.
    [J]. HELICOBACTER, 2008, 13 (05) : 447 - 447
12345